Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Redmond

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Bioanalysis|May 1, 2023
Characterization of murine lymphocyte activation and exhaustion markers by a 14-color flow cytometry panelDaniel C Rose, Annah S Rolig, William L Redmond
Plos One|April 13, 2012
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expressionWilliam L Redmond, Todd Triplett, Kevin Floyd, et al.
Journal for Immunotherapy of Cancer|March 6, 2015
Professional development session for early career scientists at SITC 2012Christian M Capitini, William L Redmond, Kimberly A Shafer-Weaver
Advances in Experimental Medicine and Biology|January 5, 2020
Immunological Complexity of the Prostate Cancer Microenvironment Influences the Response to ImmunotherapyNataliya Prokhnevska, Dana A Emerson, Haydn T Kissick, et al.
Plos One|February 17, 2021
Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancersZhaoyu Sun, Richard Nyberg, Yaping Wu, et al.
European Journal of Immunology|December 22, 2006
Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responsesCarl E Ruby, William L Redmond, Daniel Haley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
The apoptotic pathway contributing to the deletion of naive CD8 T cells during the induction of peripheral tolerance to a cross-presented self-antigenWilliam L Redmond, Cheng-Hong Wei, Huub T C Kreuwel, et al.
Journal for Immunotherapy of Cancer|November 21, 2014
Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8(+) T cellsMichael J McNamara, Melissa J Kasiewicz, Stefanie N Linch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonistWilliam L Redmond, Michael J Gough, Bridget Charbonneau, et al.
Cancer Research|July 3, 2008
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumorMichael J Gough, Carl E Ruby, William L Redmond, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Bioanalysis|May 1, 2023
Characterization of murine lymphocyte activation and exhaustion markers by a 14-color flow cytometry panelDaniel C Rose, Annah S Rolig, William L Redmond
Plos One|April 13, 2012
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expressionWilliam L Redmond, Todd Triplett, Kevin Floyd, et al.
Journal for Immunotherapy of Cancer|March 6, 2015
Professional development session for early career scientists at SITC 2012Christian M Capitini, William L Redmond, Kimberly A Shafer-Weaver
Advances in Experimental Medicine and Biology|January 5, 2020
Immunological Complexity of the Prostate Cancer Microenvironment Influences the Response to ImmunotherapyNataliya Prokhnevska, Dana A Emerson, Haydn T Kissick, et al.
Plos One|February 17, 2021
Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancersZhaoyu Sun, Richard Nyberg, Yaping Wu, et al.
European Journal of Immunology|December 22, 2006
Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responsesCarl E Ruby, William L Redmond, Daniel Haley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
The apoptotic pathway contributing to the deletion of naive CD8 T cells during the induction of peripheral tolerance to a cross-presented self-antigenWilliam L Redmond, Cheng-Hong Wei, Huub T C Kreuwel, et al.
Journal for Immunotherapy of Cancer|November 21, 2014
Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8(+) T cellsMichael J McNamara, Melissa J Kasiewicz, Stefanie N Linch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonistWilliam L Redmond, Michael J Gough, Bridget Charbonneau, et al.
Cancer Research|July 3, 2008
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumorMichael J Gough, Carl E Ruby, William L Redmond, et al.
Pageof 7